Publication | Open Access

Neutral sphingomyelinase inhibition participates to the benefits of N-acetylcysteine treatment in post-myocardial infarction failing heart rats

ThrombosisHeart FailureCardiovascular DiseaseN-acetylcysteine TreatmentPhysiologyPharmacologyCardiologyNeutral Sphingomyelinase InhibitionHeart RatsAcute Myocardial InfarctionMedicineAtherosclerosisOxidative StressMyocardial Infarction